# US 2016/0249602 A1 · Method for pooling hepatocytes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0249602 A1
- Document ID: US20160249602A1
- Status: Published application
- Kind: A1
- Application number: 15/054,476
- Filed: 2016-02-26
- Published: 2016-09-01
- Earliest claimed: 2015-02-27
- Assignees: Triangle Research Labs, LLC
- Inventors: Matthew Sherman; Robert Kaiser
- Web page: https://patentgrep.com/patent/US20160249602A1

## CPC

- A01N 1/122: Preservation or perfusion media
- A01N 1/16: Physical preservation processes
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS

## Abstract

The present invention relates to a novel method for the preparation of a pooled or mixed population of cryopreserved cells (e.g. hepatocytes). In particular, the invention entails the rapid thaw of cells (e.g. hepatocytes), donated from a single individual, which are mixed to create a heterogeneous population and then cryopreserved. The invention also concerns preparations of multi-cryopreserved cells to increase viability prior to immediate use. The process entails reducing exposure to chemical and physical stresses to increase the resultant number of viable cells.

## Claims

### Claim 1

A method for cryopreserving hepatocytes from multiple sources comprising the steps of:
A) thawing hepatocytes from a plurality of sources;
B) pooling the hepatocytes from the plurality of sources into a preservation solution;
C) centrifuging the pooled hepatocytes to cause pelleting;
D) removing the preservation solution;
E) combining the viable and non-viable pelleted hepatocytes with a cryopreservative;
F) distributing the pooled hepatocytes into vials
G) cryopreserving the hepatocytes in the vials

### Claim 2 (depends on 1)

The method of claim 1, wherein said hepatocytes are selected from the group comprising: human hepatocytes, porcine hepatocytes, simian hepatocytes, canine hepatocytes, feline hepatocytes, bovine hepatocytes, equine hepatocytes, ovine hepatocytes and rodent hepatocytes

### Claim 3 (depends on 1)

The method of claim 1, wherein said multiple sources are comprised of a random or pre-selected group based on gender, race, age, metabolic state or health state.

### Claim 4 (depends on 1)

The method of claim 1, wherein the preservation solution is comprised of University of Wisconsin solution, HyperThermosol-Base, or HyperThermosol-FRS.

### Claim 5 (depends on 4)

The method of claim 4, wherein the preservation solution is further comprised of fetal bovine serum.

### Claim 6 (depends on 1)

The method of claim 1, wherein distributing the pooled cells is done at a density greater than 10 million cells/ml.

### Claim 7 (depends on 1)

The method of claim 1, wherein the centrifugation step is devoid of a density gradient.

### Claim 8 (depends on 1)

The method of claim 1, wherein the centrifugation step is performed to pellet both viable and non-viable cells.

### Claim 9 (depends on 1)

The method of claim 1, further including thawing the pooled cryopreserved cells and applying a density gradient fractionation process.

### Claim 10 (depends on 9)

The method of claim 9, wherein the density gradient centrifuging step is performed between 50-200 RCF.

### Claim 11 (depends on 9)

The method of claim 9, wherein said density gradient fractionation comprises density centrifugation through polyvinylpyrrolidone-coated colloidal silica particles.

### Claim 12 (depends on 2)

The method of claim 2, wherein the hepatocytes are either used in suspension or plated.

### Claim 13 (depends on 1)

The method of claim 1, wherein the combining of pelleted hepatocytes with cryopreservative further includes one or more of the following steps: pipetting up and down, vortexing, rocking vial back and forth, or tapping the vial.
